Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products
Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo: ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, today announces that the company welcomes the judgment rendered by the Paris Commercial Court in the case brought by Pixium Vision against Second Sight Medical Products, Inc. (renamed Vivani Medical, Inc.) following the latter's withdrawal from the proposed business combination between the two companies1 on April 2, 2021
By Pixium Vision
Published - Dec 28, 2022, 01:03 AM ET
Last Updated - Apr 29, 2024, 05:03 AM EDT
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products